Search Results - Pereira, Jason Luke

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Continuous variable port-based teleportation

    Continuous variable port-based teleportation by Pereira, Jason L, Banchi, Leonardo, Pirandola, Stefano

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Statistical Complexity of Quantum Learning

    Statistical Complexity of Quantum Learning by Banchi, Leonardo, Jason Luke Pereira, Sharu, Theresa Jose, Simeone, Osvaldo

    Published in arXiv.org
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Statistical Complexity of Quantum Learning

    Statistical Complexity of Quantum Learning by Banchi, Leonardo, Pereira, Jason Luke, Jose, Sharu Theresa, Simeone, Osvaldo

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  4. 4
    Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trial

    Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trial by McMahon, James H., Lau, Jillian S.Y., Coldham, Anna, Roney, Janine, Hagenauer, Michelle, Price, Sally, Bryant, Mellissa, Garlick, Jill, Paterson, Anne, Lee, Sue J., O'Bryan, Jess, Hearps, Anna, Tachedjian, Gilda, Pinskier, Henry, Phillips, Cameron, Garrow, Stuart, Pinskier, Nathan, Melvin, Robert, Blakeway, Luke, Wisniewski, Jessica A., Byers, Sally, Badoordeen, Gnei Z., Pereira, Stephanie, Pragastis, Katherine, Trubiano, Jason A., Chua, Kyra Y.L., Kainer, Marion, Molton, James S., Gardiner, Bradley J., Pierce, Anna B., Cheng, Allen, Rogers, Benjamin A., Peleg, Anton Y.

    Published in EClinicalMedicine
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Phase 1/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined With Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Malignancies

    Phase 1/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined With Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Mali... by Luke, Jason J, Gelmon, Karen, Siu, Lillian L, Moreno, Victor, Desai, Jayesh, Gomez-Roca, Carlos A, Carlino, Matteo S, Pachynski, Russell K, Cosman, Rasha, Chu, Quincy Siu-Chung, Damian, Silvia, Curigliano, Giuseppe, Tam, Rachel, Wang, Xianling, Jeyamohan, Chandrika, Wang, Lily, Zhu, Li, Santucci-Pereira, Julia, Greenawalt, Danielle M, Tabernero, Josep

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: